SLS
SELLAS Life Sciences Group Inc. Common Stock
$1.650+0.000 (0.000%)
即時價格
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.650
最高
$1.650
最低
$1.650
交易量
2.61M
公司基本面
交易統計
相關新聞
GlobeNewswire
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for
查看更多
GlobeNewswire
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。